rs61730895
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001012720.2(RGR):c.722C>T(p.Ser241Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0439 in 1,614,066 control chromosomes in the GnomAD database, including 1,868 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_001012720.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RGR | NM_001012720.2 | c.722C>T | p.Ser241Phe | missense_variant | 6/7 | ENST00000652092.2 | NP_001012738.1 | |
RGR | NM_002921.4 | c.734C>T | p.Ser245Phe | missense_variant | 6/7 | NP_002912.2 | ||
RGR | NM_001012722.2 | c.631-524C>T | intron_variant | NP_001012740.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RGR | ENST00000652092.2 | c.722C>T | p.Ser241Phe | missense_variant | 6/7 | NM_001012720.2 | ENSP00000498299.1 |
Frequencies
GnomAD3 genomes AF: 0.0397 AC: 6042AN: 152182Hom.: 179 Cov.: 32
GnomAD3 exomes AF: 0.0524 AC: 13161AN: 251384Hom.: 430 AF XY: 0.0524 AC XY: 7122AN XY: 135862
GnomAD4 exome AF: 0.0444 AC: 64882AN: 1461764Hom.: 1688 Cov.: 32 AF XY: 0.0453 AC XY: 32966AN XY: 727192
GnomAD4 genome AF: 0.0397 AC: 6041AN: 152302Hom.: 180 Cov.: 32 AF XY: 0.0413 AC XY: 3076AN XY: 74474
ClinVar
Submissions by phenotype
not provided Benign:2Other:1
not provided, no classification provided | literature only | NEI Ophthalmic Genomics Laboratory, National Institutes of Health | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Retinal dystrophy Benign:1
Benign, criteria provided, single submitter | research | Dept Of Ophthalmology, Nagoya University | Oct 01, 2023 | - - |
Retinitis pigmentosa Benign:1
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Mar 06, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at